N-[(1,2-二氢-6-甲基-2-氧代-4-丙基-3-吡啶基)甲基]-1-(1-甲基乙基)-6-[6-[4-(1-甲基乙基)-1-哌嗪基]-3-吡啶基]-1H-吲唑-4-甲酰胺
![N-[(1,2-二氢-6-甲基-2-氧代-4-丙基-3-吡啶基)甲基]-1-(1-甲基乙基)-6-[6-[4-(1-甲基乙基)-1-哌嗪基]-3-吡啶基]-1H-吲唑-4-甲酰胺结构式](https://image.chemsrc.com/caspic/340/1431612-23-5.png)
N-[(1,2-二氢-6-甲基-2-氧代-4-丙基-3-吡啶基)甲基]-1-(1-甲基乙基)-6-[6-[4-(1-甲基乙基)-1-哌嗪基]-3-吡啶基]-1H-吲唑-4-甲酰胺结构式
|
常用名 | N-[(1,2-二氢-6-甲基-2-氧代-4-丙基-3-吡啶基)甲基]-1-(1-甲基乙基)-6-[6-[4-(1-甲基乙基)-1-哌嗪基]-3-吡啶基]-1H-吲唑-4-甲酰胺 | 英文名 | UNC1999 |
|---|---|---|---|---|
| CAS号 | 1431612-23-5 | 分子量 | 569.740 | |
| 密度 | 1.2±0.1 g/cm3 | 沸点 | 804.7±65.0 °C at 760 mmHg | |
| 分子式 | C33H43N7O2 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 440.4±34.3 °C | |
| 符号 |
GHS07 |
信号词 | Warning |
|
EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells.
Cancer Biol. Ther. 15(12) , 1677-87, (2014) Metastatic colon cancer has a 5-year survival of less than 10% despite the use of aggressive chemotherapeutic regimens. As signaling from epidermal growth factor receptor (EGFR) is often enhanced and epigenetic regulation is often altered in colon cancer, it ... |
期刊文献综述：
更多...